Education
About Us
Working with TipRanks
Follow Us
Veronica Bulis Sanchez Insider Profile
4 Followers
Veronica Bulis Sanchez, VP, Corporate Controller at Lyell Immunopharma, holds 9.21K shares in Lyell Immunopharma (Ticker: LYEL). Most recently, Veronica Bulis Sanchez Sold 239 shares of Lyell Immunopharma on Nov 12, 2025 for an estimated value of $3.85K.
Veronica Bulis Sanchez has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Veronica Bulis Sanchez's holdings
Insider Roles
VP, Corporate Controller
Roles that Veronica Bulis Sanchez holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Veronica Bulis Sanchez
Veronica Bulis Sanchez's Trading History
List of latest transactions for each holding click on a transaction to see Veronica Bulis Sanchez's performance on stock
You May Also Like
Veronica Bulis Sanchez insider profile FAQ
What is the percentage of profitable transactions made by Veronica Bulis Sanchez?
The percentage of profitable transactions made by Veronica Bulis Sanchez is ―.
What is the average return per transaction made by Veronica Bulis Sanchez?
The average return per transaction made by Veronica Bulis Sanchez is ―.
What stocks does Veronica Bulis Sanchez hold?
Veronica Bulis Sanchez holds: LYEL stocks.
What was Veronica Bulis Sanchez’s latest transaction?
Veronica Bulis Sanchez latest transaction was an Informative Sell of $3.85K.
What was Veronica Bulis Sanchez's most profitable transaction?
Veronica Bulis Sanchez’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Veronica Bulis Sanchez's role in Lyell Immunopharma?
Veronica Bulis Sanchez's role in Lyell Immunopharma is VP, Corporate Controller.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.